Prof. Laurent Azoulay
May 2024Research at the Lady Davis Institute

Combining diabetes medications reduces risk of certain adverse effects, study finds

Risk of adverse cardiovascular and renal events is lower when specific types of diabetes medication are combined, researchers say.

READ MORE →
Dr. Lawrence Rosenberg
April 2016Research at the Lady Davis Institute

Landmark clinical trial under way for type 1 diabetes treatment

Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.

READ MORE →